Answers are grounded in this paper and cite their sources.
Introduction. According to current research, the novel coronavirus infection (COVID-19) has an adverse impact on pregnancy and its outcomes. However, data on the causes of preterm birth in women who had COVID-19 during the current pregnancy remain insufficient. Aim. To determine serum concentrations of 8-isoprostane and 12-hydroxyeicosatetraenoic acid (12-HETE) as predictors of preterm birth in pregnant women with COVID-19. Materials and methods. This prospective comparative study involved three groups of pregnant women. The main group (n = 42) included patients diagnosed with moderately severe COVID-19 (community-acquired pneumonia) and threatened preterm labor. The comparison group (n = 51) comprised patients with moderately severe COVID-19 (community-acquired pneumonia) but with-out threatened preterm labor. The control group (n = 35) consisted of patients without threatened preterm labor and no history of COVID-19, either previously or at the time of examination. Diagnosis was confirmed by detecting SARS-CoV-2 RNA in oropharyngeal and nasopharyngeal swabs by polymerase chain reaction (PCR), as well as current clinical and radiological criteria of viral lung involvement using specialized imaging methods (as indicated). Serum 8-isoprostane was measured by enzyme-linked immunosorbent assay (ELISA) with Cayman Chemical (USA) reagent kits, and 12-HETE was determined using Enzo Life Sciences (USA) reagent kits. Results. In the main group, the median serum 8-isoprostane concentration was 381.85 (375.43–388.30) pg/mL and 12-HETE was 8.73 (8.48–8.81) ng/mL – both higher than in the comparison group (200.00 (185.33–210.99) pg/mL and 2.99 (2.31–3.41) ng/mL) and the control group (178.20 (173.35–184.00) pg/mL, p< 0.001; 2.22 (1.96–2.35) ng/mL, p< 0.001, respectively). Based on discriminant analysis, a mathematical model was developed to calculate a prognostic risk index for preterm birth (PRIPB): PRIPB = -7.607 + 0.022 × 8-isoprostane + 0.309 × 12-HETE. The threshold PRIPB value was 3.244. A PRIPB ≥3.244 indicates a high risk of preterm birth, meaning higher PRIPB values are directly proportional to the risk of preterm birth. A PRIPB < 3.244 suggests no risk of preterm birth. Among 38 women in the main group, the predicted outcome matched the actual result in 90 % of cases. Conclusion. For the first time, an elevated level of 12-HETE was identified alongside an increase in 8-isoprostane in women with COVID-19 during the third trimester of pregnancy. In patients with moderately severe COVID-19, serum concentrations of 8-isoprostane and 12-HETE appear to be markers of preterm birth risk.
No takes yet. Share an insight, caveat, or question.
Ишутина et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: